Literature DB >> 34649222

Better Late Than Never?! Five Compelling Reasons for Putting Physical Activity in Low- and Middle-Income Countries High Up on the Public Health Research Agenda.

Katja Siefken, Andrea Ramirez Varela, Temo Waqanivalu, Nico Schulenkorf.   

Abstract

Since 2020, the world has been navigating an epidemiologic transition with both infectious diseases (COVID-19) and noncommunicable diseases intertwined in complex and diverse ways. In fact, the pandemics of physical inactivity, noncommunicable diseases, and COVID-19 coincide in a tragically impactful ménage à trois with their detrimental long-term health consequences yet to be determined. We know that people in low- and middle-income countries not only have the highest risk of developing chronic diseases, they also develop the diseases at a younger age, they suffer longer, and they die earlier than people in high-income countries. This commentary features 5 compelling reasons for putting physical activity in low- and middle-income countries high up on the public health research agenda and calls for more commitment to inclusive and context-specific public health practices that are paired with locally relevant promotion and facilitation of PA practice, research, and policymaking.

Entities:  

Keywords:  Global South; non-communicable diseases; sport-for-development; sport-for-health

Mesh:

Year:  2021        PMID: 34649222     DOI: 10.1123/jpah.2021-0576

Source DB:  PubMed          Journal:  J Phys Act Health        ISSN: 1543-3080


  2 in total

1.  Validity and Reliability of the Daily Activity Behaviours Questionnaire (DABQ) for Assessment of Time Spent in Sleep, Sedentary Behaviour, and Physical Activity.

Authors:  Kaja Kastelic; Nejc Šarabon; Michael D Burnard; Željko Pedišić
Journal:  Int J Environ Res Public Health       Date:  2022-04-28       Impact factor: 4.614

2.  Development of the Brazilian Version of a Pan-Canadian Behavior Change Program and Its Health and Fitness Outcomes.

Authors:  Juliano Schwartz; Paul Oh; Shannon S D Bredin; Ryan E Rhodes; Maira B Perotto; Alejandro Gaytán-González; Darren E R Warburton
Journal:  J Clin Med       Date:  2022-10-08       Impact factor: 4.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.